Multi-omics analysis unveils tumor heterogeneity and immunotherapy predictive model in breast cancer for precision medicine and early detection
This study provides a comprehensive view of the genetic and immune determinants of breast cancer heterogeneity, with a focus on BLBC's role in immune escape and treatment resistance. These insights enhance the potential of multi-omics approaches in precision prevention, early detection, and personalized immunotherapy strategies.
Authors
- Shenglu Jiang (ORCID: https://orcid.org/0009-0005-4133-6912)
- Xiufeng Tang (ORCID: https://orcid.org/0000-0001-9863-4236)
- Lingling Zhang (ORCID: https://orcid.org/0000-0001-8136-8795)
- Zhencang Zheng (ORCID: https://orcid.org/0009-0000-8706-0062)
- Zhenxiong Zhao
Institutions
- Taizhou Central Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Neoplasia
- Published
- 2025-12-03
- DOI
- https://doi.org/10.1016/j.neo.2025.101260
- Citations
- 1
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.52